| 貨號(hào) | 規(guī)格 | 價(jià)格 | 上海 | 北京 | 武漢 | 南京 | 購買數(shù)量 |
|---|---|---|---|---|---|---|---|
S82130-5mg |
99.9% | ￥650.00 | 6 | - | - | - |
|
S82130-10mg |
99.9% | ￥1200.00 | 7 | - | - | - |
|
S82130-25mg |
99.9% | ￥2400.00 | 6 | - | - | - |
|
S82130-50mg |
≥98% | ￥4200.00 | 貨期：2-3天 | - | - | - |
|
CB-7921220 is an adenylate cyclase inhibitor.
| 產(chǎn)品描述： | CB-7921220 is an adenylate cyclase inhibitor. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點(diǎn)： | Adenylate Cyclase;AChR | ||||||||||||||||||||
| 體外研究： | CB-7921220 shows a degree of isoform selectivity for adenylate cyclase (AC) 1, but cannot distinguish between AC1 and AC6. CB-7921220 has a more consistent predicted binding position in the two virtual docking screens, and has a binding conformation similar to ATP and P-site inhibitors, which may explain its lack of selectivity between AC1 and AC6 | ||||||||||||||||||||
| 參考文獻(xiàn)： | 1. Brand CS, et al. Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds. J Pharmacol Exp Ther. 2013 Nov;347(2):265-75. | ||||||||||||||||||||
| 溶解性： | soluble in DMSO | ||||||||||||||||||||
| 保存條件： | -20℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網(wǎng)安備 31011702002021號(hào)
危險(xiǎn)品化學(xué)品經(jīng)營許可證（不帶存儲(chǔ)）
營業(yè)執(zhí)照(三證合一)
北京